24.01.2014 Views

Full document - International Hospital Federation

Full document - International Hospital Federation

Full document - International Hospital Federation

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Innovation in clinical specialities: cardiovascular disease<br />

number of deaths postponed or prevented but did not alter the<br />

relative contribution of each risk factor (Table 5, columns 5 and 6).<br />

Thus, regardless of whether best, minimum or maximum<br />

estimates were considered, the most substantial contributions<br />

came from the changes in cholesterol, blood pressure and<br />

smoking (Table 5).<br />

Discussion<br />

Success in achieving the HP2010 targets could almost halve<br />

predicted CHD deaths in 2010, or indeed in 2015. Our findings are<br />

reassuringly consistent with earlier studies in the England, 23<br />

Scotland 22 and the USA 12 . In the United Kingdom, a modest<br />

reduction in mean population cholesterol level from 225 mg/dl to<br />

200 mg/dl could reduce CHD deaths by approximately half. 14,15,24 In<br />

contrast, a rather optimistic 25% reduction in the prevalence of<br />

obesity would probably prevent just 2% of CHD deaths. 15,24 A<br />

corresponding 25% reduction in the prevalence of inactivity might<br />

prevent 1% of CHD deaths. 15,29<br />

Although CHD death rates have been falling in the USA for four<br />

decades, they are now plateauing in young men and women. 2<br />

Recent declines in total cholesterol have been modest, blood<br />

pressure is now rising among women and obesity and diabetes are<br />

20 000<br />

0<br />

-20 000<br />

-40 000<br />

-60 000<br />

-80 000<br />

-100 000<br />

-120 000<br />

-140 000<br />

-160 000<br />

-180 000<br />

-5000<br />

-45 000<br />

-85 000<br />

-125 000<br />

-28 300<br />

-33 540<br />

C holes terol<br />

-103 080<br />

25-34<br />

355-300<br />

1525 2235<br />

-1525<br />

2190<br />

-48 635<br />

Systo lic B P<br />

-82 520<br />

35-44<br />

-4190<br />

-12 175<br />

Smoking<br />

-10 020 -6810<br />

-12 010<br />

-26 270<br />

-33 670<br />

-60 135<br />

IF Current trends continue to 2010<br />

IF Healthy People 2010 targets<br />

IF USA Low Risk stratum<br />

-20815<br />

45-54<br />

-45 770<br />

-1450<br />

IF Current trends continue to 2010<br />

IF Healthy People 2010 targets<br />

IF USA Low Risk stratum<br />

-43 615<br />

55-64<br />

-88 500<br />

8105<br />

BMI<br />

P hysical A ctivity<br />

-17 430<br />

-20 535<br />

-8775<br />

-52 300<br />

65-74<br />

-106 295<br />

15885<br />

rising steeply. Furthermore, population aging will increase the<br />

numbers of CHD deaths in that country and elsewhere. 30 There is<br />

no room for complacency. Continuation of recent risk factor trends<br />

should result in approximately 20 000 fewer coronary deaths in<br />

2010 than in 2000. This reflects some 50 000 fewer deaths<br />

expected from improvements in total cholesterol, smoking, physical<br />

activity and male blood pressure, but more than half of the gain is<br />

negated by approximately 30 000 additional deaths attributable to<br />

increases in rates of obesity and diabetes, plus systolic blood<br />

pressure increases among women. Increasing treatments could<br />

not compensate for these worsening risk factors. In 2000, barely<br />

40% of eligible patients received appropriate therapies. 10 Even<br />

raising this proportion to an optimistic 50% would only postpone<br />

approximately 60 000 additional deaths in 2010. 31<br />

Successfully achieving the specific risk factor reductions<br />

proposed in the HP2010 targets could prevent or postpone<br />

approximately 190 000 CHD deaths. This would potentially halve<br />

the mortality burden seen in 2000. The HP2010 objectives for<br />

cholesterol and physical activity remain potentially attainable.<br />

However, attaining the targets for obesity, diabetes and female<br />

blood pressure appear more challenging because of the need to<br />

actually reverse recent adverse trends. 3 Successfully reducing<br />

population risk factor levels to those already seen in<br />

the healthiest (lowrisk) stratum could result in<br />

approximately 370 000 fewer CHD deaths among<br />

people aged 25–84 years. This figure would represent<br />

a 96% decrease compared to the 2000 baseline of<br />

388 000 1,3 and is somewhat larger than the 85%<br />

reduction predicted by other studies. 24,25 Although<br />

probably an overestimate, the results for this third<br />

scenario show an aspirational ideal to highlight<br />

potential future gains. However, the “low-risk stratum”<br />

in the population of the USA remains frustratingly<br />

small, even when defined only by smoking, blood<br />

-71 860<br />

pressure and cholesterol: 6% in the 1970s 32 and,<br />

even now, only 7.5% among whites and 4% among<br />

African Americans. 33<br />

-43 900<br />

-11 840<br />

-61 790<br />

Diabetes<br />

Figure 1: Estimated reductions in coronary heart disease mortality in the United<br />

. States 2. Estimated of America reductions in 2010 under in coronary three different heart disease scenarios mortality in the United State<br />

75-84<br />

-119 705<br />

Figure 2: Estimated reductions in coronary heart disease mortality in the United<br />

States of America in 2010 by age group under three different scenarios<br />

Achieving risk factor reductions<br />

Although fashionable, screening and treating high-risk<br />

individuals would necessitate medicating 15% to<br />

25% of all adults. 34,35 Furthermore, the key goal is not<br />

intervention but sustained risk factor reductions. 35 The<br />

whole population approach described by Rose 13<br />

appears both more effective and cost-effective. 13–15<br />

Similar conclusions have been reported previously in<br />

Dutch, Finnish and American cohorts. 12,35<br />

Lowering cholesterol should therefore remain a<br />

priority in the USA, as it offers a potentially powerful<br />

1% mortality reduction for every 1 mg/dl decrease in<br />

total cholesterol. 6 Large cholesterol declines have<br />

already been achieved by comprehensive national<br />

policies elsewhere (-20% in Finland 18 and -15% in<br />

Mauritius 36 ). In contrast, in the USA between 1988<br />

and 2004 total cholesterol fell barely 3% in adults<br />

(from 206 to 201 mg/dl). 37 Furthermore, these levels<br />

remain well above the optimal, prompting recent<br />

national dietary policies to further reduce total<br />

cholesterol levels. 2,3,38<br />

<strong>Hospital</strong> and Healthcare Innovation Book 2009/2010 73

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!